No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer
- 30 August 2005
- journal article
- research article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 25 (1), 115-117
- https://doi.org/10.1002/cbf.1274
Abstract
Methylenetetrahydrofolate reductase (MTHFR) is an enzyme (EC 1.5.1.20), that reduces 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a carbon donor for the homocysteine to methionine conversion. MTHFR is a keyenzyme that regulates folate metabolism which has an important role in DNA synthesis, DNA repair and methylation. The association between MTHFR C677T polymorphism and breast cancer has been investigated in several previous studies. Some researchers have shown an association between C677T polymorphism and breast cancer, but not all researchers found this association however. This study was designed to investigate, in the Turkish population, the association of MTHFR C677T polymorphism and breast cancer. Forty women patients with breast cancer and 68 healthy women were included in the study. MTHFR gene polymorphism was determined by the PCR-RFLP method. SPSS 10.0 for windows was used to determine statistical significance. No differences were observed in the distribution of MTHFR genotypes or allele frequencies in the cases versus the controls. It was found that the frequencies of MTHFR polymorphism were 55%, 40%, 5% for CC, CT, TT genotype in patients and 56%, 38%, 6% in healthy controls respectively. Furthermore, association was observed among family history, metastatic risk and MTHFR genotypes in patients. Our data fail to support a relationship between MTHFR C677T and the risk for breast cancer. It may be that there are ethnic differences in terms of this relationship. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: The Fukuoka Colorectal Cancer StudyCancer Science, 2004
- Reduced breast cancer risk with increasing serum folate in a case–control study of the C677T genotype of the methylenetetrahydrofolate reductase geneEuropean Journal of Cancer, 2004
- Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean womenExperimental & Molecular Medicine, 2004
- MTHFR Polymorphisms, Dietary Folate Intake, and Breast Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2004
- Breast cancer risk and methylenetetrahydrofolate reductase polymorphism.Breast Cancer Research and Treatment, 2003
- Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR)Cancer Letters, 2002
- DNA damage from micronutrient deficiencies is likely to be a major cause of cancerMutation research. Reviews in mutation research, 2001
- Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish womenEuropean Journal of Cancer, 2000
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988